论文部分内容阅读
目的探讨喘可治注射液治疗支气管哮喘临床疗效。方法 56例支气管哮喘患者按随机数字表法随机分为治疗组和对照组,各28例。对照组采用常规治疗,治疗组在此基础上采用喘可治注射液雾化吸入,两组均治疗14 d,观察疗效。结果治疗组总有效率为96.4%,对照组总有效率为82.1%,治疗组疗效及肺功能改善均优于对照组,差异具有统计学意义(P<0.05)。结论雾化吸入喘可治注射液治疗支气管哮喘疗效确切,安全可靠,值得推广应用。
Objective To investigate the clinical efficacy of Chuankezhi injection in the treatment of bronchial asthma. Methods Fifty-six patients with bronchial asthma were randomly divided into treatment group (n = 28) and control group (n = 28) by random number table method. In the control group, conventional treatment was used. On the basis of this, the treatment group received asthma inhalation by inhalation of Chuankezhi, and both groups were treated for 14 days to observe the curative effect. Results The total effective rate was 96.4% in the treatment group and 82.1% in the control group. The treatment group and the improvement of lung function were better than the control group, the difference was statistically significant (P <0.05). Conclusion inhalation of asthma treatment can be treated bronchial asthma curative effect is exact, safe and reliable, it is worth to promote the application.